19-55157437-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000363.5(TNNI3):​c.12-129A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.256 in 1,580,076 control chromosomes in the GnomAD database, including 64,130 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 13194 hom., cov: 32)
Exomes 𝑓: 0.24 ( 50936 hom. )

Consequence

TNNI3
NM_000363.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.130

Publications

13 publications found
Variant links:
Genes affected
TNNI3 (HGNC:11947): (troponin I3, cardiac type) Troponin I (TnI), along with troponin T (TnT) and troponin C (TnC), is one of 3 subunits that form the troponin complex of the thin filaments of striated muscle. TnI is the inhibitory subunit; blocking actin-myosin interactions and thereby mediating striated muscle relaxation. The TnI subfamily contains three genes: TnI-skeletal-fast-twitch, TnI-skeletal-slow-twitch, and TnI-cardiac. This gene encodes the TnI-cardiac protein and is exclusively expressed in cardiac muscle tissues. Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM). Troponin I is useful in making a diagnosis of heart failure, and of ischemic heart disease. An elevated level of troponin is also now used as indicator of acute myocardial injury in patients hospitalized with moderate/severe Coronavirus Disease 2019 (COVID-19). Such elevation has also been associated with higher risk of mortality in cardiovascular disease patients hospitalized due to COVID-19. [provided by RefSeq, Aug 2020]
TNNI3 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • dilated cardiomyopathy 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hypertrophic cardiomyopathy 7
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • cardiomyopathy, familial restrictive, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy 1FF
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated restrictive cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 19-55157437-T-C is Benign according to our data. Variant chr19-55157437-T-C is described in ClinVar as Benign. ClinVar VariationId is 1264197.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.651 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNNI3NM_000363.5 linkc.12-129A>G intron_variant Intron 1 of 7 ENST00000344887.10 NP_000354.4 P19429Q6FGX2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNNI3ENST00000344887.10 linkc.12-129A>G intron_variant Intron 1 of 7 1 NM_000363.5 ENSP00000341838.5 P19429
ENSG00000267110ENST00000587871.1 linkn.*131+125A>G intron_variant Intron 5 of 8 5 ENSP00000473050.1 M0R381

Frequencies

GnomAD3 genomes
AF:
0.365
AC:
55478
AN:
151830
Hom.:
13154
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.657
Gnomad AMI
AF:
0.147
Gnomad AMR
AF:
0.404
Gnomad ASJ
AF:
0.214
Gnomad EAS
AF:
0.441
Gnomad SAS
AF:
0.441
Gnomad FIN
AF:
0.226
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.201
Gnomad OTH
AF:
0.360
GnomAD4 exome
AF:
0.245
AC:
349428
AN:
1428128
Hom.:
50936
Cov.:
27
AF XY:
0.248
AC XY:
175709
AN XY:
709880
show subpopulations
African (AFR)
AF:
0.677
AC:
22182
AN:
32784
American (AMR)
AF:
0.490
AC:
21374
AN:
43660
Ashkenazi Jewish (ASJ)
AF:
0.213
AC:
5329
AN:
24980
East Asian (EAS)
AF:
0.421
AC:
16567
AN:
39370
South Asian (SAS)
AF:
0.414
AC:
35031
AN:
84622
European-Finnish (FIN)
AF:
0.231
AC:
12129
AN:
52494
Middle Eastern (MID)
AF:
0.334
AC:
1885
AN:
5648
European-Non Finnish (NFE)
AF:
0.201
AC:
218314
AN:
1085554
Other (OTH)
AF:
0.282
AC:
16617
AN:
59016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
13598
27195
40793
54390
67988
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8088
16176
24264
32352
40440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.366
AC:
55586
AN:
151948
Hom.:
13194
Cov.:
32
AF XY:
0.367
AC XY:
27288
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.658
AC:
27214
AN:
41388
American (AMR)
AF:
0.404
AC:
6173
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.214
AC:
744
AN:
3472
East Asian (EAS)
AF:
0.441
AC:
2273
AN:
5156
South Asian (SAS)
AF:
0.440
AC:
2120
AN:
4816
European-Finnish (FIN)
AF:
0.226
AC:
2398
AN:
10588
Middle Eastern (MID)
AF:
0.306
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
0.201
AC:
13668
AN:
67946
Other (OTH)
AF:
0.367
AC:
772
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1504
3008
4512
6016
7520
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
498
996
1494
1992
2490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.303
Hom.:
5402
Bravo
AF:
0.392
Asia WGS
AF:
0.521
AC:
1809
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
8.8
DANN
Benign
0.57
PhyloP100
0.13
PromoterAI
-0.024
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11671293; hg19: chr19-55668805; COSMIC: COSV61276034; COSMIC: COSV61276034; API